Friedman G, Silva E, Vincent JL. 敗血症性ショックの死亡率は時間とともに変化しているか? Crit Care Med.

Angus DC, Linde-Zwirble WT, Lidicker J. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated cost of care. Crit Care Med. 2001;29:1303-10.

Martin GS, Mannino DM, Eaton S. The epidemiology of sepsis in the United States from 1979 to 2000. N Engl J Med. 2003;348:1546-54.

Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8:222-6.

Dombrovskiy VY, Martin AA, Sunderram J. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244-50.

Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.

Investigators ProCESS, Yealy DM, Kellum JA. 初期の敗血症性ショックに対するプロトコルベースのケアの無作為化試験。 N Engl J Med. 2014;370:1683-93.

早期敗血症性ショックの患者に対する目標指向型の蘇生法。 N Engl J Med. 2014;371:1496-506.

Mouncey PR, Osborn TM, Power GS. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock(初期の敗血症性ショックに対する目標指向型のプロトコル化された蘇生法の臨床効果と費用対効果に関する多施設共同無作為化対照試験)。 N Engl J Med. 2015;372:1301-11.

Phua J, Koh Y, Du B. Management of severe sepsis in patients admitted to Asian intensive care unit: prospective cohort study. BMJ. 2011;342:d3245.

Beale R, Reinhart K, Brunkhorst FM. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009;37:222-32.

. .

Marx G, Reinhart K. Venous oximetry. Curr Opin Crit Care. 2006;12:263-8.

ACCP/SCCM Consensus Conference:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepse(敗血症と臓器不全の定義と敗血症における革新的治療法の使用に関するガイドライン)。 Crit Care Med. 1992;20:864-74.

Richard C, Warszawski J, Anguel N. Early Use of pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2003;290:2713-20.

Wheeler AP, Bernard GR, Thompson BT.

Wheeler AP, Bernard GR, Thompson BT.急性肺損傷の治療を誘導するための肺動脈カテーテルと中心静脈カテーテルの比較。 N Engl J Med. 2006;354:2213-24.

Harvey S, Harrison DA, Singer M. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomized controlled trial. Lancet.

Dellinger RP, Levy MM, Rhodes A. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.

重症敗血症/敗血症性ショックの重症患者の治療における早期の目標指向型治療の効果:多施設、前向き、無作為化、対照研究。 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue.

Chawla LS, Zia H, Gutierrez G. Lack of equalence between central and mixed venous oxygen saturation. Chest. 2004;126:1891-6.

Varpula M, Karlsson S, Ruokonen E. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med. 2006;32:1336-43.

Van Beest PA, van Ingen J, Boerma EC. 敗血症における混合静脈と中心静脈の飽和度は、敗血症の起源によらず一致しない。 Crit Care. 2010;14:R219.

Gattinoni L, Brazzi L, Pelosi P. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025-32.

コメントを残す

メールアドレスが公開されることはありません。 * が付いている欄は必須項目です